Scientific journal
Научное обозрение. Медицинские науки
ISSN 2500-0780
ПИ №ФС77-57452

Personal portfolio

PROGNOSTICS IMPORTANT MARKERS AT PATIENTS MULTIPLE MYELOMA

Baratova D.A. 1 Baratova M.A. 2
1 NMU «Eurasian Center oncohematology
2 AO «Republican Scientific Center of Emergency Medical Assistance» Astana
The article presents the results of research, allowing the disease at an early stage multiple myeloma (MM) to identify significant diagnostic features: (anemia), pathological content of plasma cells (14 %) in the bone marrow punctate, high concentrations of creatinine, calcium, monoclonal paraprotein (from 20 % and higher) in serum. These signs are laboratory-diagnostic markers in multiple myeloma patients kirghiz ethnic and high risk factors for disease progression. These studies are being conducted for the first time among patients with MM residents of Kirghizia. According to the results of our study in MM patients in kirghiz ethnic 58–62 % of the cases detected IgA myeloma with chronic renal failure.k-type has a high risk of progression. IgA-variant myeloma light chains of immunoglobulins are often. Patients suffering from multiple myeloma immunochemical one IgA myeloma or Ig A selection of high-needs timely programs of chemotherapy and autologous bone marrow transplantation or unrelated bone marrow transplantation with a view to maximize the effectiveness of treatment.